Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:29 PM
Ignite Modification Date:
2025-12-24 @ 6:29 PM
NCT ID:
NCT03769168
Eligibility Criteria:
Key Inclusion Criteria:
* Patients had to have participated in the core study CAIN457F2304 and completed the entire treatment period up to and including Week 104.
* Patients had to be deemed by the investigator to benefit from continued secukinumab therapy.
Key Exclusion Criteria:
* Patients with plans for administration of live vaccines during the extension study period were excluded.
* Patients taking any other concomitant biologic immunomodulating agent(s) except secukinumab were excluded.
* Patients who were deemed not to be benefiting from the study treatment based on lack of improvement or worsening of their symptoms were excluded.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Years
Maximum Age:
100 Years
Study:
NCT03769168
Study Brief:
Protocol Section:
NCT03769168